Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells

• Thilo S. Lange ,

  Contributed equally to this work with: Thilo S. Lange, Kyu Kwang Kim

  Affiliations Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital of RI, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America, Department of Biology and Medicine, Brown University, Providence, Rhode Island, United States of America

  ⨯
• Kyu Kwang Kim ,

  Contributed equally to this work with: Thilo S. Lange, Kyu Kwang Kim

  Affiliation Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital of RI, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯
• Rakesh K. Singh,

  Affiliation Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital of RI, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯
• Robert M. Strongin,

  Affiliation Department of Chemistry, Portland State University, Portland, Oregon, United States of America

  ⨯
• Carolyn K. McCourt,

  Affiliation Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital of RI, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯
• Laurent Brard

  * E-mail: lbrard@wihri.org

  Affiliation Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital of RI, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America

  ⨯